91 related articles for article (PubMed ID: 2061572)
1. One year treatment with clonidine in children with constitutional growth delay.
Moreno Esteban B; Monereo Mejías S; Rodríguez Poyo-Guerrero P; Moreno Esteban FJ; Tresguerres JA
J Endocrinol Invest; 1991 Feb; 14(2):75-9. PubMed ID: 2061572
[TBL] [Abstract][Full Text] [Related]
2. Clonidine treatment for short stature.
Pintor C; Cella SG; Loche S; Puggioni R; Corda R; Locatelli V; Müller EE
Lancet; 1987 May; 1(8544):1226-30. PubMed ID: 2884368
[TBL] [Abstract][Full Text] [Related]
3. Augmentation of growth hormone secretion in children with constitutional growth delay by short term clonidine administration: a pulse amplitude-modulated phenomenon.
Loche S; Puggioni R; Fanni T; Cella SG; Müller EE; Pintor C
J Clin Endocrinol Metab; 1989 Feb; 68(2):426-30. PubMed ID: 2918053
[TBL] [Abstract][Full Text] [Related]
4. Effect of prolonged clonidine administration on growth hormone concentrations and rate of linear growth in children with constitutional growth delay.
Castro-Magaña M; Angulo M; Fuentes B; Castelar ME; Cañas A; Espinoza B
J Pediatr; 1986 Nov; 109(5):784-7. PubMed ID: 3095519
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children.
de Waal WJ; Greyn-Fokker MH; Stijnen T; van Gurp EA; Toolens AM; de Munick Keizer-Schrama SM; Aarsen RS; Drop SL
J Clin Endocrinol Metab; 1996 Mar; 81(3):1206-16. PubMed ID: 8772601
[TBL] [Abstract][Full Text] [Related]
6. Lack of benefit of clonidine treatment for short stature in a double-blind, placebo-controlled trial.
Pescovitz OH; Tan E
Lancet; 1988 Oct; 2(8616):874-7. PubMed ID: 2902319
[TBL] [Abstract][Full Text] [Related]
7. [Clinical use of growth hormone and clonidine in growth disorders].
Vinci VS; Masotti G; Citro G; DeMarca S; Quaglia C
Medicina (Firenze); 1989; 9(3):288-91. PubMed ID: 2615602
[TBL] [Abstract][Full Text] [Related]
8. [Effects of clonidine++ administration in children with familial short stature and retarded body growth].
Dorantes-Alvarez L; Coyote-Estrada N; Parra-Paredes S; García-Morales L; Metlich-Medlich B
Bol Med Hosp Infant Mex; 1992 Jul; 49(7):422-6. PubMed ID: 1418649
[TBL] [Abstract][Full Text] [Related]
9. [Clonidine in the treatment of short stature: preliminary clinical experience].
Calzolari G; Bellini M; Alboni S; Riva P; Bonati E
G Clin Med; 1990; 71(8-9):517-20. PubMed ID: 2279627
[TBL] [Abstract][Full Text] [Related]
10. Oxandrolone in constitutionally delayed growth, a longitudinal study up to final height.
Joss EE; Schmidt HA; Zuppinger KA
J Clin Endocrinol Metab; 1989 Dec; 69(6):1109-15. PubMed ID: 2584350
[TBL] [Abstract][Full Text] [Related]
11. Management of the short stature due to pubertal delay in boys.
Adan L; Souberbielle JC; Brauner R
J Clin Endocrinol Metab; 1994 Feb; 78(2):478-82. PubMed ID: 7508951
[TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
[TBL] [Abstract][Full Text] [Related]
13. Failure of dehydroepiandrosterone enanthate to promote growth.
Sizonenko PC; Paunier L
J Clin Endocrinol Metab; 1986 Jun; 62(6):1322-4. PubMed ID: 2939100
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children.
Boguszewski M; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1995 Sep; 80(9):2599-606. PubMed ID: 7673401
[TBL] [Abstract][Full Text] [Related]
15. Management of children with short stature.
O'Shea D; Byrne M; Powell D
Ir Med J; 1990 Mar; 83(1):25-7. PubMed ID: 2361835
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development.
Carel JC; Hay F; Coutant R; Rodrigue D; Chaussain JL
J Clin Endocrinol Metab; 1996 Sep; 81(9):3318-22. PubMed ID: 8784090
[TBL] [Abstract][Full Text] [Related]
17. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
18. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic short stature: results of a one-year controlled study of human growth hormone treatment. Genentech Collaborative Study Group.
J Pediatr; 1989 Nov; 115(5 Pt 1):713-9. PubMed ID: 2681637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
